Latest news
- Beating Blood Cancers Blog
- Our publications
- Dedicated to beating blood cancers
- Disease newsletters
- Lifeblood
- Willing to help
- Lymphoma News
- Lymphoma News: October 2019
- ‘First of its kind’ blood cancer report proposes new optimal care pathway for people with lymphoma
- ABMDR recruitment campaign – 5000 new stem cell donors by September 2020
- Bronwyn advocated for when and where she was treated
- Shine a light on blood cancer at Light the Night
- WhiMSICAL study – on the way to 1000 participants and ‘big data’
- Lymphoma News: August 2019
- Lymphoma News: June 2019
- Lymphoma News: October 2019
- Living Well News
- Living Well News: Issue 1 / 2019
- Cancer-related fatigue – what it is, how it can affect you and how to manage it
- Cherryl meditates to reduce stress and for her healing
- Cooking for chemo recipes: comfort food for winter
- Talking humanity in healthcare with David Joske
- Tereena goes to her “happy place” when she’s in pain or discomfort
- The mind/body connection in healing
- Living Well News: Issue 2 / 2019
- Living Well News: Issue 1 / 2019
- MDS News
- MDS News: October 2019
- ‘First of its kind’ blood cancer report includes opportunities for improved treatment for MDS
- ABMDR recruitment campaign – 5000 new stem cell donors by 2020
- Merrick from Berwick has “reported for duty” since 2012
- Quest to better understand MDS and find out more effective therapies
- Shine a light on blood cancer at Light the Night
- MDS News: September 2019
- MDS News: October 2019
- CLL e-News
- CLL e-News: November 2019
- CLL e-News: September 2019
- Cancer Concierge Pilot: Assessing CLL needs and providing targeted interventions
- Chemo-free drug – Venetoclax – now listed on the PBS for CLL
- Going through treatment has taken the worry out of watch and wait for Patricia
- Information, insights, even exercise covered at the CLL patient forum
- September spotlights blood cancer and our bold new goal
- CML News
- Moving towards achieving the vision of Zero Lives Lost to Blood Cancer by 2035
- Q&A: Professor Timothy Hughes – Part 1
- Q&A: Professor Timothy Hughes – Part 2
- Rick’s “very happy” with his decision to change to generic imatinib
- Asciminib – the biggest breakthrough yet in CML treatment
- Caring for the Carer
- A bone marrow transplant saved Judi’s life after a shock diagnosis
- AML News
- Subscribe
- Latest news
- Social media
- Videos
- Media contacts
Australians raise the bar for the Leukaemia Foundation’s U.G.L.Y Bartender of the Year
More than 800 bartenders across the country have come together to be ‘U.G.L.Y.’ for the Leukaemia Foundation’s U.G.L.Y. Bartender of the Year awards. The extraordinary group of Aussies raised a massive $920,000 to pay for 11,500 nights of accommodation, essential for regional families affected by blood cancer who must
Leukaemia Foundation supports latest Pharmaceutical Benefits Scheme (PBS) listings for blood cancer patients
Monday September 30 2019
The Leukaemia Foundation has welcomed news Australians living with Philadelphia chromosome B-cell precursor acute lymphocytic leukaemia (B-ALL) will now have access to treatment options blinatumumab (Blincyto®) and inotuzumab ozogamicin (Besponsa®) through the Pharmaceuticals Benefits Scheme (PBS) effective October 1, 2019.
Leukaemia Foundation CEO Bill Petch joined Federal
Australia’s National Blood Cancer Taskforce meets for first time
Monday September 30 2019
The Leukaemia Foundation established the Blood Cancer Taskforce with the support of the Federal Government to develop Australia’s first National Strategic Action Plan for Blood Cancer.
Co-chaired by Bill Petch (CEO, Leukaemia Foundation) and Professor John Seymour (Director of Cancer Medicine, Clinical Research and Haematology, Peter MacCallum
Chronic myeloid leukaemia to affect five times as many Australians and take three times as many lives by 2035
Friday September 20 2019
A recent report released by the Leukaemia Foundation has found more than five times as many Australians will be diagnosed with chronic myeloid leukaemia come 2035, and the number of Australians losing their life to the rare blood cancer will more than triple.
The report shows
Swab a cheek to save a life, this World Marrow Donor Day
Friday September 20 2019
Every year, more than 600 Australians living with blood cancer will need an allogeneic stem cell transplant to survive.
To access that life-saving treatment, some patients will find a stem cell donor within their own family. However, 70 per cent rely on a complete stranger to donate
Bridgestone network reaffirms Leukaemia Foundation support through new funding initiative
Wednesday 18 September 2019
Australia’s most trusted tyre brand, Bridgestone, and its nation-wide network of Bridgestone retail stores, has announced a three-year extension with long-term charity partner, the Leukaemia Foundation. The declaration coincides with the launch of a new way for
World Awareness Day for Australia’s most common blood cancer
Sunday 15 September 2019
A recent report released by the Leukaemia Foundation has revealed the true size and impact of the blood cancer lymphoma in Australia is far greater than was previously known.
The report shows currently around 6500 Australians will be diagnosed every year with a lymphoma making it Australia’s most common
Leukaemia Foundation shines spotlight on National MPN Awareness Day today
The Leukaemia Foundation is today honoring Australians living with the rare blood disorder Myeloproliferative Neoplasms (MPNs) as part of National MPN Awareness Day.
MPNs are just some of the many rare blood disorders which are seeing a rise in incidence, prevalence and mortality. More than 1205 Australians are diagnosed with
New national report reveals impact of blood cancer
Sunday 1 September 2019
A first-of-its-kind nationwide report commissioned by the Leukaemia Foundation reveals the true size, scale and impact of blood cancer and the lived experiences of people living with blood cancer in Australia today.
The Leukaemia Foundation has today marked the start of Blood Cancer
Local legacy to help fund blood cancer researchers of tomorrow
Friday 23 August 2019
A generous legacy by the family of a Cleveland local will help the Leukaemia Foundation support the next generation of Australian blood cancer researchers.
Cor Frederik (10.9.1927 – 25.9.2017) was businessman, scholar, author, investor, art collector and company director with a flourishing accounting practice in Cleveland, a